---
title: Main Page
permalink: /learning-portal/main-page/
description: ""
---
### Learning Portal

Learning Portal, an online catalogue of our training and education initiatives,  
provides you an easy way to explore different programmes that would best fit your learning needs and preferences.

<table>
	<tbody>
		<tr>
			<td style="width:33%">
				<img src="/images/Learning%20Portal/webinar_square-website-1.png">
				<a href="/learning-portal/natural-killer-nk-cell-therapeutics-in-nasopharyngeal-cancer-npc/">
					<br>
					<b>NATURAL KILLER (NK) CELL THERAPEUTICS IN NASOPHARYNGEAL CANCER (NPC)</b>
				</a>
					<br><br>
					Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer, primarily endemic in Singapore, Southeast Asia and Southern China. A large majority (~70%) of NPC patients present with locally advanced disease at diagnosis and carry a high risk of recurrence (~30%) following definitive chemoradiotherapy (CRT). These relapses are highly lethal and current chemotherapies can prolong ...				
			</td>
			<td style="width:33%">
				<img src="/images/Learning%20Portal/webinar_square-website-1.png">
				<a href="/learning-portal/natural-killer-nk-cell-therapeutics-in-nasopharyngeal-cancer-npc/">
					<br>
					<b>NATURAL KILLER (NK) CELL THERAPEUTICS IN NASOPHARYNGEAL CANCER (NPC)</b>
				</a>
					<br><br>
					Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer, primarily endemic in Singapore, Southeast Asia and Southern China. A large majority (~70%) of NPC patients present with locally advanced disease at diagnosis and carry a high risk of recurrence (~30%) following definitive chemoradiotherapy (CRT). These relapses are highly lethal and current chemotherapies can prolong ...				
			</td>
			<td style="width:33%">
				<img src="/images/Learning%20Portal/webinar_square-website-1.png">
				<a href="/learning-portal/natural-killer-nk-cell-therapeutics-in-nasopharyngeal-cancer-npc/">
					<br>
					<b>NATURAL KILLER (NK) CELL THERAPEUTICS IN NASOPHARYNGEAL CANCER (NPC)</b>
				</a>
					<br><br>
					Nasopharyngeal carcinoma (NPC) is an aggressive head and neck cancer, primarily endemic in Singapore, Southeast Asia and Southern China. A large majority (~70%) of NPC patients present with locally advanced disease at diagnosis and carry a high risk of recurrence (~30%) following definitive chemoradiotherapy (CRT). These relapses are highly lethal and current chemotherapies can prolong ...				
			</td>
		</tr>
	</tbody>
	</table>